Extensive research has shown that patients with CKD exhibit elevated levels of inflammatory mediators, such as high-sensitivity C-reactive protein, interleukin IL-6, and tumor necrosis factor-α (Kim et al., 2023; Zhang et al., 2017; Gao et al., 2023). The gene discussed is IL6; the disease is chronic kidney disease.